Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 173,415 | 57,937 | 71,064 | 98,426 | 0 |
| Marketable Securities | 555,231 | 130,333 | 185,480 | 77,277 | 0 |
| Receivables | 1,698 | 383 | 83 | 25 | 0 |
| TOTAL | $735,815 | $192,705 | $258,948 | $176,869 | $0 |
| Non-Current Assets | |||||
| PPE Net | 10,807 | 9,330 | 11,107 | 11,230 | 0 |
| Investments And Advances | 6,440 | 0 | 4,383 | 682 | 0 |
| Other Non-Current Assets | 19,230 | 1,075 | 487 | 1,705 | 0 |
| TOTAL | $36,477 | $10,405 | $15,977 | $13,617 | $N/A |
| Total Assets | $772,292 | $203,110 | $274,925 | $190,486 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,682 | 4,704 | 3,102 | 3,820 | 0 |
| Accrued Expenses | 27,850 | 9,522 | 6,023 | 3,137 | 0 |
| Other current liabilities | 3,566 | 1,480 | 1,560 | 769 | 0 |
| TOTAL | $121,669 | $22,706 | $16,935 | $12,726 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 74,571 | 7,000 | 6,250 | 5,000 | N/A |
| Other Non-Current Liabilities | 15,786 | 4,540 | 6,064 | 5,305 | 0 |
| TOTAL | $148,319 | $16,562 | $23,048 | $23,892 | $N/A |
| Total Liabilities | $269,988 | $39,268 | $39,983 | $36,618 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,876 | 45,974 | 44,535 | N/A | N/A |
| Common Shares | 6 | 4 | 4 | N/A | 0 |
| Retained earnings | -328,184 | -205,326 | -122,828 | -73,234 | 0 |
| Other shareholders' equity | 44 | 64 | -107 | 226,154 | 0 |
| TOTAL | $502,304 | $163,842 | $234,942 | $153,868 | $0 |
| Total Liabilities And Equity | $772,292 | $203,110 | $274,925 | $190,486 | $0 |